Research to Practice: Sunday nite
Read More
ST_AM
Chicago, IL - ASCO 2013 Annual Meeting: - Hideyuki Yoshitomi during Abstract 4056 - Poster 18B - Hideyuki Yoshitomi - Poster Discussion Session: A randomized phase II trial of adjuvant chemotherapy with S-1 versus S-1 and gemcitabine (GS) versus gemcitabine alone (GEM) in patients with resected pancreatic cancer (CAP-002 study). at the American Society for Clinical Oncology (ASCO) Annual Meeting here today, Monday June 3, 2013. Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the meeting which is being held at the McCormick Convention center and features the latest cancer research in the areas of basic and clinical science. Photo by © ASCO/Todd Buchanan 2013 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org
